Your browser doesn't support javascript.
loading
More Research Is Needed to Quantify Risks, Benefits, and Cost-Effectiveness of Universal Mupirocin Usage.
Deeny, Sarah R; Worby, Colin J; Tosas Auguet, Olga; Cooper, Ben S; Edgeworth, Jonathan; Cookson, Barry; Robotham, Julie V.
Afiliação
  • Deeny SR; Modelling and Economics Unit, Centre for Infectious Disease Surveillance and Control, Public Health England and Health Protection Research Unit in Modelling Methodology, London, United Kingdom.
  • Worby CJ; Center for Communicable Disease Dynamics, Harvard School of Public Health, Boston, Massachusetts.
  • Tosas Auguet O; Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, United Kingdom.
  • Cooper BS; Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, United Kingdom Mahidol-Oxford Tropical Medicine Research Unit, Bangkok, Thailand.
  • Edgeworth J; Department of Infectious Diseases, Centre for Clinical Infection and Diagnostics Research, King's College London Guy's and St Thomas' NHS Foundation Trust.
  • Cookson B; Division of Infection and Immunity, University College London, United Kingdom.
  • Robotham JV; Modelling and Economics Unit, Centre for Infectious Disease Surveillance and Control, Public Health England and Health Protection Research Unit in Modelling Methodology, London, United Kingdom.
Clin Infect Dis ; 62(9): 1193-4, 2016 May 01.
Article em En | MEDLINE | ID: mdl-26908798

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Mupirocina / Análise Custo-Benefício Tipo de estudo: Etiology_studies / Health_economic_evaluation Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Mupirocina / Análise Custo-Benefício Tipo de estudo: Etiology_studies / Health_economic_evaluation Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article